| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
João Remi de Freitas Júnior, Igor Braga Ribeiro, Diogo Turiani Hourneaux de Moura, Vitor Massaro Takamatsu Sagae, Gabriel Mayo Vieira de Souza, Guilherme Henrique Peixoto de Oliveira, Sergio A Sánchez-Luna, Thiago Ferreira de Souza, Eduardo Turiani Hourneaux de Moura, Cláudia Pinto Marques Souza de Oliveira, Wanderley Marques Bernardo and Eduardo Guimarães Hourneaux de Moura |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Igor Braga Ribeiro, MD, Doctor, Research Fellow, Surgeon, Gastrointestinal Endoscopy Unit, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Av. Dr Enéas de Carvalho Aguiar, 225, 6o andar, bloco 3, São Paulo 05403-010, Brazil. igorbraga1@gmail.com |
| Key Words |
Intragastric balloon; Metabolic dysfunction-associated fatty liver disease; Homeostatic model assessment; Abdominal circumference; Body mass index |
| Core Tip |
Metabolic dysfunction-associated fatty liver disease (MAFLD) corresponds to the accumulation of fat in the liver and is linked with metabolic dysregulation. We evaluated the effects of the intragastric balloon (IGB) in patients with MAFLD through the assessment of liver enzymes, imaging, and several metabolic markers. Outcomes analyzed before and after 6 mo of IGB placement were alanine aminotransferase (IU/L), gamma-glutamyltransferase (IU/L), glycosylated hemoglobin (%), and other parameters related to metabolic disorders. This is the first systematic review and meta-analysis to assess the role of the IGB in the new definition of MAFLD. |
| Publish Date |
2021-07-23 08:10 |
| Citation |
de Freitas Júnior JR, Ribeiro IB, de Moura DTH, Sagae VMT, de Souza GMV, de Oliveira GHP, Sánchez-Luna SA, de Souza TF, de Moura ETH, de Oliveira CPMS, Bernardo WM, de Moura EGH. Effects of intragastric balloon placement in metabolic dysfunction-associated fatty liver disease: A systematic review and meta-analysis. World J Hepatol 2021; 13(7): 815-829 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i7/815.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i7.815 |
